SAM
RMD icon

SEB Asset Management’s ResMed RMD Stock Holding History

SEB Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.6M Buy
146,730
+6,700
+5% +$1.39M 0.11% 168
2026
Q1 		$31.4M Buy
+140,030
New +$34.9M 0.13% 137

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SEB Asset Management's RMD Position: Q2 2026 in Review

SEB Asset Management increased its ResMed (RMD) stake by 4.8% in Q2 2026, buying an estimated $1.39M and bringing the position to 146,730 shares worth $28.6M. The position accounts for 0.11% of the portfolio, ranked #168.

SEB Asset Management first reported a position in RMD in Q1 2026 and has held it in 2 quarters since. The position peaked at $31.4M in Q1 2026. 836 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • SEB Asset Management held 146,730 shares of ResMed worth $28.6M as of Q2 2026.
  • SEB Asset Management bought 6,700 ResMed shares in Q2 2026, an estimated $1.39M.
  • ResMed made up 0.11% of SEB Asset Management's portfolio in Q2 2026, its #168 holding.
  • SEB Asset Management first reported a position in ResMed in Q1 2026 and has held it in 2 quarters since.
  • SEB Asset Management's ResMed position peaked at $31.4M in Q1 2026.
  • 836 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on SEB Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.